Ignite Creation Date:
2025-12-24 @ 12:00 PM
Ignite Modification Date:
2026-01-06 @ 3:19 PM
Study NCT ID:
NCT05398861
Status:
UNKNOWN
Last Update Posted:
2022-06-01
First Post:
2022-05-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
Sponsor:
Henan Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-22
First Submit QC Date:
None
Study First Post Date:
2022-06-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-26
Last Update Post Date:
2022-06-01
Last Update Post Date Type:
ACTUAL